Therefore, search for novel anti-inflammatory agent for T1D therapy is practically significant.
← all excerpts
Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways.
1
—
—